| __timestamp | ACADIA Pharmaceuticals Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 5758000 |
| Thursday, January 1, 2015 | 76369000 | 8423000 |
| Friday, January 1, 2016 | 4406000 | 11986000 |
| Sunday, January 1, 2017 | 13060000 | 15215000 |
| Monday, January 1, 2018 | 18330000 | 15356000 |
| Tuesday, January 1, 2019 | 19598000 | 16660000 |
| Wednesday, January 1, 2020 | 20550000 | 52459000 |
| Friday, January 1, 2021 | 19141000 | 75061000 |
| Saturday, January 1, 2022 | 10166000 | 87221000 |
| Sunday, January 1, 2023 | 45731000 | 83779000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc. have shown distinct trends in their cost of revenue. ACADIA's costs peaked in 2015, reaching nearly 76 million, before experiencing a significant decline, dropping to just over 10 million by 2022. In contrast, Supernus Pharmaceuticals saw a steady increase, with costs surging by over 1,400% from 2014 to 2023, peaking at approximately 87 million in 2022. This divergence highlights the strategic differences between the two companies. While ACADIA appears to have streamlined its operations, Supernus has expanded aggressively. These insights provide a window into the operational strategies of these pharmaceutical giants, offering valuable lessons for investors and industry analysts alike.
Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Catalent, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down ADMA Biologics, Inc. and ACADIA Pharmaceuticals Inc.'s Expenses
Amneal Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Xencor, Inc.
Cost of Revenue: Key Insights for Supernus Pharmaceuticals, Inc. and Xencor, Inc.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.'s Expenses